TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.10M | -9.52M | -6.66M | -6.00M | -5.58M |
| Total Depreciation and Amortization | 21.30K | 13.40K | 14.10K | 17.60K | 29.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | 171.40K | 668.80K |
| Total Other Non-Cash Items | 1.95M | 1.41M | 1.42M | 1.08M | 248.10K |
| Change in Net Operating Assets | -5.95M | 1.86M | 487.20K | 2.13M | 1.40M |
| Cash from Operations | -11.09M | -6.25M | -4.74M | -2.60M | -3.23M |
| Capital Expenditure | 0.00 | -5.60K | -42.70K | -21.40K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -150.90K | -1.11M | -5.99M | -5.19M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 5.19M | -- |
| Cash from Investing | 0.00 | -156.50K | -1.15M | -823.50K | -5.19M |
| Total Debt Issued | -- | -- | -- | 0.00 | 9.50M |
| Total Debt Repaid | -576.30K | -- | -- | -796.90K | -- |
| Issuance of Common Stock | 6.20M | 9.03M | 504.20K | 13.80K | 7.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.10K | -2.10K | -2.10K | -- | -- |
| Other Financing Activities | -348.00K | -331.40K | -1.05M | -2.73M | -829.40K |
| Cash from Financing | 5.27M | 8.70M | -547.90K | -3.52M | 15.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.82M | 2.29M | -6.44M | -6.94M | 7.28M |